secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adverum Biotechnologies, Inc. (—)
CIK:        0001501756
Form:       8-K
Filed at:   2022-11-25T23:59:59+00:00
Accession:  0001140361-22-043051
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Adverum receives Nasdaq bid-price deficiency notice; has until May 17, 2023 to comply
--------------------------------------------------------------------------------

- Received Nasdaq letter on Nov 18, 2022; bid price closed below $1.00 for 30 consecutive business days.
- Has 180 calendar days (until May 17, 2023) to regain compliance with minimum bid price of $1.00 for 10 consecutive business days.
- If not compliant by May 17, 2023, may be eligible for a second 180-day period if it meets other listing standards.
- Company intends to monitor bid price and evaluate options, including a potential reverse stock split.
- Currently meets all other continued listing requirements; failure to cure could lead to delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501756/000114036122043051/0001140361-22-043051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501756/000114036122043051/brhc10044678_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-043051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer